Skip to main content
Premium Trial:

Request an Annual Quote

Gene Data, Novartis

Premium

Gene Data of Basel, Switzerland, last week released two new modules for its analysis suite of products.

The firm, a 1997 spinout from Novartis, introduced Screener Condenser and Screener Analyst for its GeneData Screener system for the analysis of high-throughput screening data.

The Condenser product performs data standardization as well as data annotation. It is designed to integrate results from primary and secondary screening into bioactivity profiles.

The Analyst product is used for cross-assay compound profiling based on HTS data. It is intended for large-scale assay comparisions, biological activity profiling of compounds or compound libraries across large numbers of assays, separation of mechanisms of actions, and identification of chemical structural elements conferring a desired biological activity. The products, together, are intended to provide a data analysis workflow. They were developed in collaboration with the pharmaceutical company Altana Pharma.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.